Share
clock Created with Sketch. 20/11/14
18:19
Share
Originally posted by TDA
↑
That's my take on it CGT, though the cost to pharma may be more using wearables compared to using say 2 x AI's. The thing is though that if the patient is more inclined to follow the course, due to rather wanting the wearable, then the pharma has to listen and provide the option imo. Some of the studies that have been conducted have shown that this is the case and that the wearables are preferred.Unilife has not provided a list of its existing clients, but it has indicated that at least one customization agreement involves multiple products. Then, too, the commercial supply agreements with existing clients may well be expanded beyond the initial number of drugs in the contracts.
Expand
Through all the knowledgeable users we have here is there any leads at all to other customers/molecules that we havnt heard of already? With 15 operations going at the present time (possibly more) there has to be a different customer/party does anyone have any ideas who they could potentially be?
